News & Events > Meetings, Conferences, & Workshops (Drugs)

News & Events > Meetings, Conferences, & Workshops (Drugs)

FDA/CDER has several upcoming workshops and conferences.  

Find details and additional offerings on CDER’s Meetings, Conferences, & Workshops (Drugs) webpage.

FDA - AACR Workshop: Non-Clinical Models for Safety Assessment of Immuno-Oncology Products.  September 6, 2018.  Washington, DC. Webcast available.  

Human Dermal (Skin) Safety Testing for Topical Drug Products: Regulatory Utility and Evaluation; Public Workshop; Request for Comments.  September 10, 2018. Silver Spring, MD. Webcast available.  

Regulatory Education for Industry (REdI): Complex Generic Drug Product Development Workshop. September 12-13, 2018. Silver Spring, MD.  Webcast available. 

Advancing the Development of Pediatric Therapeutics 5 (ADEPT5):  Advancing Pediatric Pharmacovigilance Public Workshop. September 14, 2018.  Silver Spring, MD.  Webcast available. 

Expanding Access to Effective Treatment for Opioid Use Disorder: Provider Perspectives on Reducing Barriers to Evidence-Based Care. September 20, 2018.  Washington, DC. 

2018 PDA/FDA Joint Regulatory Conference, Putting Patients First: Ensuring Innovation, Quality, Compliance, and Supply in an Evolving Environment. September 24-26, 2018, Washington, D.C.  

Evidence-Based Treatment Decisions In Transplantation: The Right Dose & Regimen for the Right Patient/Individualized Treatment. September 27-28, 2018, Silver Spring, MD. Webcast available. 

FDA-HESI Public Workshop:  Preclinical and Translational Safety Assessment of CD3 Bispecifics.  October 1-2, 2018.  Silver Spring.  Webcast available.

Electronic Drug Registration and Listing Using CDER Direct .  October 2, 2018. Silver Spring, MD. Webcast available.